Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0YX2B
|
|||
| Drug Name |
PMID28460551-Compound-2
|
|||
| Drug Type |
Small molecular drug
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C22H27FN4O2
|
|||
| Canonical SMILES |
CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C
|
|||
| InChI |
1S/C22H27FN4O2/c1-5-27(6-2)10-9-24-22(29)20-13(3)19(25-14(20)4)12-17-16-11-15(23)7-8-18(16)26-21(17)28/h7-8,11-12,25H,5-6,9-10H2,1-4H3,(H,24,29)(H,26,28)/b17-12-
|
|||
| InChIKey |
WINHZLLDWRZWRT-ATVHPVEESA-N
|
|||
| CAS Number |
CAS 557795-19-4
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:38940
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Cancer stem cell (CSC) inhibitors: a review of recent patents (2012-2015).Expert Opin Ther Pat. 2017 Jul;27(7):753-761. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.